SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-220908
Filing Date
2013-05-15
Accepted
2013-05-15 07:47:41
Documents
14
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d512142d10q.htm 10-Q 523316
2 EX-10.3 d512142dex103.htm EX-10.3 65185
3 EX-10.4 d512142dex104.htm EX-10.4 65724
4 EX-10.5 d512142dex105.htm EX-10.5 65157
5 EX-31.1 d512142dex311.htm EX-31.1 6961
6 EX-31.2 d512142dex312.htm EX-31.2 6978
7 EX-32.1 d512142dex321.htm EX-32.1 3804
8 EX-32.2 d512142dex322.htm EX-32.2 3807
  Complete submission text file 0001193125-13-220908.txt   3080166

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT idra-20130331.xml EX-101.INS 283673
10 XBRL TAXONOMY EXTENSION SCHEMA idra-20130331.xsd EX-101.SCH 40659
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idra-20130331_cal.xml EX-101.CAL 35503
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idra-20130331_def.xml EX-101.DEF 129339
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20130331_lab.xml EX-101.LAB 258763
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20130331_pre.xml EX-101.PRE 177076
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 13843727
SIC: 2836 Biological Products, (No Diagnostic Substances)